Results 111 to 120 of about 3,980 (127)
Advancing treatment efficacy: combined therapy of eribulin, anlotinib, and camrelizumab in advanced or metastatic retroperitoneal liposarcoma. [PDF]
Ther Adv Med OncolJia W +8 more
europepmc +1 more source
Optimizing surgical strategies for retroperitoneal liposarcoma: a comprehensive evaluation of standardized aggressive surgical policies. [PDF]
BMC CancerLiu DN +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The importance of the margin of resection and radiotherapy in retroperitoneal liposarcoma
American Journal of Surgery, 2021Michael J Littau +2 more
exaly
Oncological outcomes after major vascular resections for primary retroperitoneal liposarcoma
European Journal of Surgical Oncology, 2021Gaya Spolverato +2 more
exaly
A review of retroperitoneal liposarcoma genomics
Cancer Treatment Reviews, 2020Robert Tyler +2 more
exaly
Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience
Asian Journal of Surgery, 2021Mizuki Onozawa +2 more
exaly
Giant retroperitoneal liposarcoma surgical management
Annals of the Royal College of Surgeons of England, 2022exaly
A case of retroperitoneal liposarcoma in pregnancy: Case Report
Acta Obstetricia Et Gynecologica Scandinavica, 1993Guido Mazzoleni, Alberto Marabini
exaly